Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > Articles by: Marie Berger
EU-PRAC recommendations on signals adopted at the 6-9 February 2023 meeting
2023 March Mar 13

EU-PRAC recommendations on signals adopted at the 6-9 February 2023 meeting

Read more
Letter to QPPVs – International Transfer of ICSRs from EV and GDPR
2023 March Mar 06

Letter to QPPVs – International Transfer of ICSRs from EV and GDPR

Read more
USA: Electronic Submission to FAERS Using E2B(R3) Standards_17Feb2023
2023 February Feb 27

USA: Electronic Submission to FAERS Using E2B(R3) Standards_17Feb2023

Read more
10 Years !
2023 January Jan 09

10 Years !

Read more
PRAC recommendations-signals adopted
2023 January Jan 06

PRAC recommendations-signals adopted

Read more
2023 January Jan 03

Read more
Italy : AIFA OPERATING PROCEDURE for local pharmacovigilance managers : Management of reports in the national pharmacovigilance network
2023 January Jan 02

Italy : AIFA OPERATING PROCEDURE for local pharmacovigilance managers : Management of reports in the national pharmacovigilance network

Read more
Monitoring of adverse drug reactions in the management of Covid-19 as of 8-Dec-2022
2022 December Dec 30

Monitoring of adverse drug reactions in the management of Covid-19 as of 8-Dec-2022

https://ansm.sante.fr/actualites/suivi-des-effets-indesirables-des-medicaments-utilises-dans-la-prise-en-charge-du-covid-19-en-date-du-8-12-2022

Read more
Denmark : Guideline Application for Individual or General Compassionate Use Permit, 16-Dec-2022
2022 December Dec 26

Denmark : Guideline Application for Individual or General Compassionate Use Permit, 16-Dec-2022

Read more
2022 December Dec 23

Read more
  • « Previous

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • European contact points for clinical trials
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023
  • Clinical Trials Regulation (EU) No 536/2014 in practice
Copyright © 2018 - Pharmya - Legal terms - Quality Policy